Work

A phase I/II study of neoadjuvant, intra-arterial administration of (177Lu)lutetium vipivotide tetraxetan in subjects with high-risk, localised or locally advanced prostate cancer (LUPUS).

Year: 2025

Type: article

Study design: Study Protocol

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.5_suppl.tps431

Authors: Claudia Kesch, Volker Meyer, Christine Praus, Pedro Fragoso Costa, Marc Ingenwerth, Christopher Darr, Jan Philipp Radtke, Jens M Theysohn, Benedikt Schaarschmidt, Henning Reis, Wolfgang Peter Fendler, Viktor Grünwald, Boris A. Hadaschik, Ken Herrmann

Institutions: University of Duisburg-Essen, ABX-CRO Advanced Pharmaceutical Services (Germany), Essen University Hospital, Stiftung Universitätsmedizin Essen, Deutsches Konsortium für Translationale Krebsforschung, Heinrich Heine University Düsseldorf, University Hospital Frankfurt

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4407699063

FWCI: 1.635

Cites:

Cited by: 3

Related to: 10